Recent Finacing
Recent Raise
Exsure develops a patented exosomal drug‑delivery platform targeting cancer and cancer stem cells, sells exosome/PBMC/plant isolation reagents, conducts nonclinical CRO studies, and pursues CDSCO approval and global expansion.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
